Production, quality control, stability and pharmacotoxicity of cGMP-produced Plasmodium falciparum AMA1 FVO strain ectodomain expressed in Pichia pastoris
- 11 November 2008
- Vol. 26 (48) , 6143-6150
- https://doi.org/10.1016/j.vaccine.2008.08.055
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Apical membrane antigen 1: a malaria vaccine candidate in reviewPublished by Elsevier ,2008
- Drug‐resistant malaria − an insightThe FEBS Journal, 2007
- A model to simulate the impact of timing, coverage and transmission intensity on the effectiveness of indoor residual spraying (IRS) for malaria controlTropical Medicine & International Health, 2006
- Insecticide-Treated NetsAdvances in Parasitology, 2006
- Aluminium adjuvants—in retrospect and prospectVaccine, 2004
- A Role for Apical Membrane Antigen 1 during Invasion of Hepatocytes by Plasmodium falciparum SporozoitesJournal of Biological Chemistry, 2004
- High-Level Expression of the Malaria Blood-Stage Vaccine CandidatePlasmodium falciparumApical Membrane Antigen 1 and Induction of Antibodies That Inhibit Erythrocyte InvasionInfection and Immunity, 2002
- Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccinesExpert Review of Vaccines, 2002
- The economic impact of malaria in Africa: a critical review of the evidenceHealth Policy, 2002
- Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical useVaccine, 1997